XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Cash Flows used in Operating Activities      
Net loss $ (46,377) $ (43,002) $ (47,505)
Adjustments to reconcile net loss to net cash used in operations:      
Non cash financing related charges 845
Share based compensation 11,549 9,438 16,370
Changes in working capital balances related to operations:      
Incentive and tax receivables 1,640 260 484
Prepaid expenses and deposits 502 (278) (299)
Accounts payable (5,378) 5,305 497
Accrued liabilities (943) (2,460) 1,350
Deferred grant income (37) (75) 473
Net cash used in operating activities (39,044) (30,812) (27,785)
Cash Flows provided by Financing Activities      
Issuance of common shares, net of share issue costs 9,198 11,284 27,875
Payment for taxes related to cashless exercise of options (2,707)
Proceeds from exercise of stock options 2,943 691 1,776
Net cash provided by financing activities 9,434 11,975 29,651
(Decrease) Increase in cash and cash equivalents during the year (29,610) (18,837) 1,866
Cash and cash equivalents, beginning of year 132,187 151,024 149,158
Cash and cash equivalents, end of year 102,577 132,187 151,024
Supplemental Cash Flow Information      
Cash paid for state and local franchise taxes 125 300 136
Common stock issued upon cashless exercise of stock options $ 1,493